Abstract:Colorectal cancer is a common digestive cancer worldwide. As a comprehensive treatment for locally advanced rectal cancer (LARC), neoadjuvant therapy (NT) has been increasingly used as the standard treatment for clinical stage II/III rectal cancer. However, few patients achieve a complete pathological response, and most patients require surgical resection and adjuvant therapy. Therefore, identifying risk factors and developing accurate models to predict the prognosis of LARC patients are of great clinical significance.To establish effective prognostic nomograms and risk score prediction models to predict overall survival (OS) and disease-free survival (DFS) for LARC treated with NT.Nomograms and risk factor score prediction models were based on patients who received NT at the Cancer Hospital from 2015 to 2017. The least absolute shrinkage and selection operator regression model were utilized to screen for prognostic risk factors, which were validated by the Cox regression method. Assessment of the performance of the two prediction models was conducted using receiver operating characteristic curves, and that of the two nomograms was conducted by calculating the concordance index (C-index) and calibration curves. The results were validated in a cohort of 65 patients from 2015 to 2017.Seven features were significantly associated with OS and were included in the OS prediction nomogram and prediction model: Vascular_tumors_bolt, cancer nodules, yN, body mass index, matchmouth distance from the edge, nerve aggression and postoperative carcinoembryonic antigen. The nomogram showed good predictive value for OS, with a C-index of 0.91 (95%CI: 0.85, 0.97) and good calibration. In the validation cohort, the C-index was 0.69 (95%CI: 0.53, 0.84). The risk factor prediction model showed good predictive value. The areas under the curve for 3- and 5-year survival were 0.811 and 0.782. The nomogram for predicting DFS included ypTNM and nerve aggression and showed good calibration and a C-index of 0.77 (95%CI: 0.69, 0.85). In the validation cohort, the C-index was 0.71 (95%CI: 0.61, 0.81). The prediction model for DFS also had good predictive value, with an AUC for 3-year survival of 0.784 and an AUC for 5-year survival of 0.754.We established accurate nomograms and prediction models for predicting OS and DFS in patients with LARC after undergoing NT.

Possible Contribution of IMRT in Postoperative Radiochemotherapy for Rectal Cancer: Analysis on 1798 Patients by Prediction Model

Neoadjuvant Radiotherapy Improves Overall Survival for T3/4N+M0 Rectal Cancer Patients: a Population-Based Study of 20300 Patients

Predictors and Risk Factors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Population-Based Analysis

Analysis of Efficacy and Prognostic Factors of Postoperative Intensity-Modulated Radiotherapy with or Without Chemotherapy in Rectal Cancer

Overall Survival Benefit in Rectal Cancer After Neoadjuvant Radiotherapy and Adjuvant Chemotherapy: A Propensity-Matched Population-Based Study

Adjuvant Treatment May Benefit Patients With High-Risk Upper Rectal Cancer: A Nomogram And Recursive Partitioning Analysis Of 547 Patients

Prognostic Factors of Rectal Cancer Treated with Multimodality Therapy Based on Surgery

MRI-based Radiomics to Predict Neoadjuvant Chemoradiotherapy Outcomes in Locally Advanced Rectal Cancer: A Multicenter Study

Nomograms and risk score models for predicting survival in rectal cancer patients with neoadjuvant therapy

MRI-based Multiregional Radiomics for Pretreatment Prediction of Distant Metastasis after Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer.

A nomogram for predicting cancer specific survival (CSS) in patients with pathological T3N0M0 (pT3N0M0) rectal cancer.

Long-term efficacy of preoperative chemoradiotherapy combined with total mesorectal excision for locally advanced rectal cancer: an analysis of 241 patients

A Nomogram Prediction Model for Lymph Node Metastasis Risk after Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients Based on SEER Database

Radiomics Features on Radiotherapy Treatment Planning CT Can Predict Patient Survival in Locally Advanced Rectal Cancer Patients

Pathologic-Based Nomograms for Predicting Overall Survival and Disease-Free Survival among Patients with Locally Advanced Rectal Cancer.

Prognostic Effects of Clinical and Pathologic Tnm Stages in Patients with Locally Advanced Rectum Carcinoma after Neoadjuvant Chemoradiotherapy

The Influence of Neoadjuvant Therapy for the Prognosis in Patients with Rectal Carcinoma: a Retrospective Study

Spatial Determinants of Response to Neoadjuvant Radiotherapy and Immunochemotherapy in Locally Advanced Mismatch Repair Proficient Rectal Cancer

Tumor Immune Microenvironment Biomarkers for Recurrence Prediction in Locally Advanced Rectal Cancer Patients after Neoadjuvant Chemoradiotherapy

Role of postoperative radiotherapy in pT3N0 rectal cancer: A risk-stratification system based on population analyses.

A Prognostic Nomogram for Overall Survival after Neoadjuvant Radiotherapy or Chemoradiotherapy in Thoracic Esophageal Squamous Cell Carcinoma: a Retrospective Analysis